In summary, IPA alleviates hyperoxia-induced alveolar arrest by promoting autophagosome-lysosome fusion via inhibition of VAMP8 phosphorylation, which is suggestive of a promising therapeutic target of BPD. This evidence concerns the gene VAMP8 and bronchopulmonary dysplasia.